The new indication for rosuvastatin is unlikely to have any significant impact on clinical practices because of questions about its clinical utility.
Ogochukwu C. Molokwu, PharmD, MScMed
Advertisement
Articles by Ogochukwu C. Molokwu, PharmD, MScMed
Advertisement
Latest Updated Articles
- Statin Therapy for Elevated hsCRP: More Evidence Is Needed
August 11th 2010
Advertisement
Advertisement
Trending on AJMC
1
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
2
Povetacicept Cuts Proteinuria by 52% in IgA Nephropathy at Week 36
3
Nephrologists Weigh Wins, Losses From 5 Years of Value-Based Kidney Care
4
Dialysis Access, Church CKD Screening Address Kidney Care Inequities
5